98%
921
2 minutes
20
X-linked immunodeficiency with magnesium defect, Epstein-Barr virus (EBV) infection, and neoplasia (XMEN) is an extremely rare inborn error of immunity (IEI) caused by X-linked recessive inheritance and loss-of-function mutations in the MAGT1 gene, resulting in magnesium ion channel defects. This article reports 2 cases of systemic EBV-positive T-cell Lymphoma of childhood (SETLC) associated with XMEN, which have not been reported before. Whole exome sequencing (WES) in their family revealed previously unreported MAGT1 gene mutations (c.77T>C, p.I26T; c.956-957del: p.Ser319Tyrfs) inherited from their mothers. These mutations expand the spectrum of gene mutations in XMEN disease. The importance of genetic testing for MAGT1 mutations in the initial diagnosis of SETLC was emphasized. We also review the literature on this uncommon IEI.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1097/MPH.0000000000002940 | DOI Listing |
J Pers Med
August 2025
Unidad de Investigación en Virología y Cáncer, Hospital Infantil de México "Federico Gómez", México City 06720, Mexico.
: X-linked agammaglobulinemia (XLA) is a prototypical inborn error of immunity (IEI) caused by mutations in the gene, leading to a profound deficiency of mature B cells and severe pan-hypogammaglobulinemia. The Epstein-Barr virus (EBV), which primarily infects B lymphocytes, is believed to be unable to establish persistence in these patients due to the lack of its natural reservoir. Indeed, current evidence supports that EBV infection is typically refractory in individuals with XLA.
View Article and Find Full Text PDFCureus
July 2025
Pediatric Emergency Medicine, The Brooklyn Hospital Center, Brooklyn, USA.
A 19-year-old transgender adolescent on hormonal therapy with a history of recent hospitalization for exudative tonsillitis presented with worsening sore throat, dysphagia, fever, and a diffuse, generalized macular rash involving the back, face, abdomen, arms, and legs. Despite prior antibiotic treatment with amoxicillin, her symptoms recurred, prompting further evaluation. Laboratory findings revealed leukocytosis with lymphocytic and monocytic predominance, elevated inflammatory markers, and a positive Epstein-Barr virus (EBV) test, confirming infectious mononucleosis.
View Article and Find Full Text PDFCureus
July 2025
Dermatology, University Hospital, Unidade Local de Saúde de Coimbra, Coimbra, PRT.
Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) is a rare and aggressive lymphoma that has been associated with age-related immunosenescence. Here, we present the case of a 79-year-old man with violaceous nodules on the skin, mainly on the lower and upper limbs, diagnosed as primary cutaneous EBV-positive diffuse large B-cell lymphoma (DLBCL) based on histopathological and immunohistochemical findings. Systemic evaluation revealed synchronous peripheral T-cell lymphoma, not otherwise specified (NOS), without systemic B-cell lymphoma involvement.
View Article and Find Full Text PDFInt J Hematol
July 2025
Department of Hematology and Biophysical Systems Analysis, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan.
Systemic chronic active Epstein-Barr virus disease (sCAEBV) is an intractable disorder characterized by clonal proliferation of EBV-infected T- and NK-cells, leading to persistent systemic inflammation and progression to hemophagocytic lymphohistiocytosis (HLH). The EBV genome encodes 40 mature microRNAs known as miR-BARTs. The expression of miR-BARTs has been reported in other EBV-positive diseases and is associated with tumorigenesis.
View Article and Find Full Text PDFMicrobiol Spectr
August 2025
Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor (Guangxi Medical University), Ministry of Education, Guangxi, China.
Epstein-Barr virus (EBV) infection is strongly associated with several malignancies, including nasopharyngeal carcinoma (NPC), Burkitt lymphoma, and certain gastric cancers, though its potential to infect endothelial cells (ECs) and the consequent pathological implications remain poorly understood. This study demonstrates through analysis of 99 NPC clinical samples (primary tumors) that Epstein-Barr virus-encoded small RNAs (EBERs) positivity in ECs significantly correlates with N stage (lymphatic metastasis, < 0.05), M stage (distant metastasis, < 0.
View Article and Find Full Text PDF